This can be attributed to the overexpression of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in tumor blood vessels, which may enhance the penetration rate of the drug compared to normal blood vessels 54. Here, VEGFA is linked to neoplasm.